Dubai Investments PJSC

Logotype for Dubai Investments PJSC
Ticker/ISIN
DIC
AED000601016
Market/Country
Dubai Financial Market
United Arab Emirates

About Dubai Investments PJSC


Country of Origin: United Arab Emirates (U.A.E)

Dubai Investments PJSC (“the Company”) is a Public Joint Stock Company incorporated in the Emirate of Dubai - United Arab Emirates by Ministerial Resolution No. 46 of 1995, on 16th July 1995. The Company’s shares are listed in the Dubai Financial Market since the year 2000. Dubai Investments is a multi-asset investment Group, managing a diverse portfolio of businesses, generating sustainable financial returns to its shareholders. 

The Company and its subsidiaries (collectively referred to as “the Group”) consists of wholly and partly owned companies and the Group’s interest and investments reflect the Company’s continued focus on business diversification to drive growth.

The Group applies insight and experience to expand and be a reliable growth driver for businesses within sectors like real estate, building materials, construction & contracting, financial services, healthcare and education among others.

Latest Pressrelease Summaries from Dubai Investments PJSC

Dubai Investments announced an 18% cash dividend, totaling AED 765.36 million, for the financial year ending December 31, 2024, which was approved at the 29th Annual General Meeting on April 16, 2025. The company reported a net profit before tax of AED 1.3 billion for 2024, a 21% increase from the previous year, reflecting its strategic growth and operational excellence. The AGM also approved a new Dividend Distribution Policy. Dubai Investments, established in 1995, is a UAE-based multi-asset investment group with a diverse portfolio in sectors such as real estate, manufacturing, and healthcare, and aims to generate sustainable financial returns and drive growth through strategic investments.
Globalpharma, a leading pharmaceutical manufacturer in the UAE and a subsidiary of Dubai Investments PJSC, has partnered with India's ZIM Laboratories to introduce EU-certified Oral Dispersible Film (ODF) technology to its product range. This technology, which meets high international quality and safety standards, was announced at the AIM Congress 2025 in Dubai. The collaboration aims to enhance the UAE's role in global pharmaceutical innovation and improve healthcare solutions. The agreement was signed by key representatives from both companies and witnessed by notable officials. Globalpharma's leaders highlighted the UAE's growing influence in pharmaceutical manufacturing and discussed industry trends at the congress. The partnership with ZIM Labs is seen as a significant step in advancing patient-centric treatment options and strengthening the region's pharmaceutical capabilities. ODFs are thin, fast-dissolving strips that improve medication compliance, especially for children, the elderly, and those with swallowing difficulties. Globalpharma plans to produce these innovative treatments locally, setting a new standard for pharmaceutical manufacturing in the region.
The disclosure clarifies the process for shareholders to delegate someone to attend the General Assembly on their behalf. Shareholders can delegate individuals who are not board members, company staff, or employees of a securities brokerage company. The delegated person can represent multiple shareholders but cannot exceed 5% of the company's issued capital. Legal representatives must represent those lacking legal capacity. The shareholder's signature on the power of attorney must be approved by specific entities such as a Notary Public, Chamber of Commerce, a bank where the shareholder has an account, licensed financial markets, or any licensed notarial entity in the UAE. The proxy form should include the shareholder's name, contact number, and the approving authority. For further inquiries, contact details are provided.
Dubai Investments PJSC reported a net profit before tax of AED 1.3 billion for the fiscal year ending December 31, 2024, marking a 21% increase from the previous year. The company's total income reached AED 4.66 billion, driven by strong real estate sales and increased rental income. Total assets grew to AED 22.10 billion by the end of 2024. The board proposed an 18% cash dividend for 2024, reflecting a commitment to shareholder value. The company plans to focus on growth by evaluating investment opportunities, strategic divestments, and potential IPOs to enhance market presence and shareholder value.
Dubai Investments announced that its subsidiaries, GlobalPharma and Emirates Float Glass (EFG), have signed Memorandums of Understanding (MOUs) during a meeting in Doha, Qatar, aimed at promoting industrial growth and sustainable development. The agreements, supported by the Ministry of Industry and Advanced Technology, involve collaboration with various regional partners. GlobalPharma signed an MOU with Morocco's Zenith Pharma to enhance pharmaceutical production, focusing on critical medications, with an investment of over $50 million. Emirates Float Glass signed an MOU to supply float glass to a regional company, enhancing cooperation in the glass manufacturing sector. GlobalPharma was recognized for its contributions to pharmaceutical research and development.
Dubai Investments has announced the launch of Asayel Avenue, a new residential cluster in the Mirdif Hills development in Dubai. Asayel Avenue will feature 193 residential units, including 1, 2, and 3-bedroom apartments, designed to offer luxury, functionality, and larger living spaces with enhanced natural light. The project, with an investment of AED 400 million, is set to begin construction in Q2 2025 and complete by Q2 2027. It aims to set new standards for community-focused living in Dubai, with amenities such as fitness centers, recreational areas, and smart living solutions. The development emphasizes green integration and balanced lifestyles, catering to the demand for premium residential options in the city.
Globalpharma, a leading pharmaceutical company in the UAE and a subsidiary of Dubai Investments PJSC, plans to launch 25 new products in 2025 across therapeutic areas such as diabetes, cardiovascular, gastroenterology, and orthopaedics. This initiative is part of Globalpharma's strategy to provide high-quality and accessible medications to meet regional healthcare needs. The company aims to strengthen its distribution network and form new partnerships to ensure product accessibility and meet the needs of healthcare practitioners and patients. Globalpharma's focus for 2025 includes innovation, accessibility, and partnerships, building on the success of previous product launches in 2024. The company's efforts align with Dubai Investments' vision to transform key industries and establish a strong presence in the global pharmaceutical sector.
Dubai Investments PJSC reported a net profit after tax of AED 650.51 million for the nine-month period ending September 30, 2024, and AED 241.31 million for the three-month period ending the same date. This represents an 80% and 78% increase, respectively, compared to the previous year when adjusted for a one-off gain. The company's total assets grew to AED 21.81 billion as of September 30, 2024, from AED 21.44 billion at the end of 2023, with equity attributable to shareholders rising to AED 13.58 billion. Khalid Bin Kalban, Vice Chairman and CEO, highlighted the group's strategic focus on sustainable growth and diversification, noting strong performance in the real estate sector and investment portfolio.

Threads

Dubai Financial Market News profile image

Dubai Financial Market News

News Update From Dubai Investments PJSC

Disclosure: Results of BOD Meeting

1. Attached Document

Dubai Financial Market News profile image

Dubai Financial Market News

News Update From Dubai Investments PJSC

Disclosure: BOD meeting

1. Attached Document

Dubai Financial Market News profile image

Dubai Financial Market News

News Update From Dubai Investments PJSC

Disclosure: Press release

Dubai Investments, a leading investment company listed on the Dubai Financial Market, has announced a 12.5% cash dividend for shareholders for the financial year ending December 31, 2023. This was approved at the company's 28th Annual General Meeting. The company reported a profit of AED 1,130.94 million for 2023, higher by AED 502.79 million if adjusted for a one-off gain from the previous year. The increase in profits is attributed to the sale of real estate properties, higher rental income, and gains on investments. The Chairman, Abdulrahman Ghanem Abdulrahman Al Mutaiwee, highlighted the company's growth plans for 2024, including expansion in the real estate sector and increased investments in Al Mal Capital and Al Mal Capital REIT. He also mentioned the company's entry into digital banking with Monument Bank and its commitment to innovation and excellence through investments in healthcare.

1. Attached Document

Dubai Financial Market News profile image

Dubai Financial Market News

News Update From Dubai Investments PJSC

Disclosure: Resolutions of General Assembly

1. Attached Document

Dubai Financial Market News profile image

Dubai Financial Market News

News Update From Dubai Investments PJSC

Disclosure: Integrated report for the year 2023

1. Attached Document

Dubai Financial Market News profile image

Dubai Financial Market News

News Update From Dubai Investments PJSC

Disclosure: Press release

Dubai Investments has announced a new residential project, Violet Tower, in Jumeirah Village Circle (JVC), Dubai. The project, valued at AED 300 Million, will be developed by Dubai Investments Real Estate (DIR) and is designed to meet the increasing demand for luxury residential apartments in the area. The 27-floor tower will comprise 287 units of studio, one, and two-bedroom apartments, along with amenities such as a swimming pool, gym, and kids' play area. Construction is set to begin in Q2 2024 and is expected to be completed within 24 months. The project aligns with the Dubai Municipality Green code, reflecting Dubai Investments' commitment to sustainable living.

1. Attached Document

Dubai Financial Market News profile image

Dubai Financial Market News

News Update From Dubai Investments PJSC

Disclosure: Financial statements for the year of 2023

The document is a directors' report and consolidated financial statements for Dubai Investments PJSC and its subsidiaries for the fiscal year ending on 31st December 2023.

1. Attached Document

Dubai Financial Market News profile image

Dubai Financial Market News

News Update From Dubai Investments PJSC

Disclosure: Results of BOD Meeting

1. Attached Document

Dubai Financial Market News profile image

Dubai Financial Market News

News Update From Dubai Investments PJSC

Disclosure: BOD meeting

1. Attached Document

DFM News profile image

DFM News

News Update From Dubai Investments PJSC

Disclosure: Preliminary financial results for the year of 2023

1. Attached Document